Answers are grounded in this paper and cite their sources.
Despite the challenges of managing medication for people with multiple long-term conditions approaching end of life, guidance remains limited. The review aim was to evaluate the effectiveness of medication management strategies in this population and identify research gaps. Eligible studies examined medication management strategies in adults ages ≥ 50 years with multiple long-term conditions approaching end of life. Studies focusing on a single condition, early-stage multimorbidity, or non-pharmacological palliative care interventions were excluded. MEDLINE, EMBASE, CINAHL, Scopus, and PsycINFO were searched from inception to September 2025. Study quality was assessed independently by two reviewers using recognized appraisal tools, with risk of bias rated as high, fair, or low. A narrative synthesis was conducted. From 14,945 records, six studies met inclusion criteria. All focused on deprescribing potentially inappropriate medications, with mixed effects on polypharmacy, regimen complexity, and clinical outcomes. The limited number of studies, all conducted in Europe, and the presence of high risk of bias in half of them, restrict generalizability. Findings suggest that deprescribing, supported by multidisciplinary and patient-centered approaches, is central to optimizing medication management at end of life in multimorbid populations. Further research is needed on broader strategies, including symptom control and anticipatory prescribing beyond deprescribing.
No takes yet. Share an insight, caveat, or question.
Adley et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: